Pictet Asset Management (Switzerland)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$576K Sell
15,982
-203,822
-93% -$6.95M ﹤0.01% 1178
2023
Q1
$8.39M Buy
219,804
+82,048
+60% +$3.85M 0.01% 657
2022
Q4
$7.84M Buy
137,756
+37,589
+38% +$1.92M 0.01% 646
2022
Q3
$3.96M Sell
100,167
-21,700
-18% -$959K 0.01% 785
2022
Q2
$5.36M Sell
121,867
-106,142
-47% -$4.59M 0.01% 745
2022
Q1
$9.09M Sell
228,009
-2,930
-1% -$104K 0.01% 671
2021
Q4
$9.29M Sell
230,939
-9,567
-4% -$357K 0.01% 688
2021
Q3
$9.78M Buy
+240,506
New +$10.1M 0.01% 671

Other funds holding HALO

Pictet Asset Management (Switzerland)'s HALO Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Halozyme (HALO) stake by 93% in Q2 2023, selling an estimated $6.95M and leaving 15,982 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Pictet Asset Management (Switzerland) first reported a position in HALO in Q3 2021 and has held it in 8 quarters since. The position peaked at $9.78M in Q3 2021. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 15,982 shares of Halozyme worth $576K as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 203,822 Halozyme shares in Q2 2023, an estimated $6.95M.
  • Halozyme made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1178 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Halozyme in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Halozyme position peaked at $9.78M in Q3 2021.
  • 370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.